Clinical TrailsImmunityBio Launches Phase 2 ResQ215B Trial for Indolent B-Cell Lymphoma ImmunityBio Launches Phase 2 ResQ215B Trial for Indolent B-Cell Lymphoma Read Post »
Health TidingsValneva and Butantan Start IXCHIQ Chikungunya Vaccination Pilot in Brazil Valneva and Butantan Start IXCHIQ Chikungunya Vaccination Pilot in Brazil Read Post »
ResearchJohnson & Johnson Calls Out Surgeon Mental Health Crisis Johnson & Johnson Calls Out Surgeon Mental Health Crisis Read Post »
Health TidingsNovo Nordisk Reports 10% Sales Growth in 2025 as Wegovy Pill Launch Strengt... Novo Nordisk Reports 10% Sales Growth in 2025 as Wegovy Pill Launch Strengt... Read Post »
Clinical TrailsNovo Nordisk’s CagriSema Outperforms Semaglutide in REIMAGINE 2 Trial Novo Nordisk’s CagriSema Outperforms Semaglutide in REIMAGINE 2 Trial Read Post »
Health TidingsSPARC’s Sezaby Approval Unlocks Rare Pediatric Priority Review Voucher SPARC’s Sezaby Approval Unlocks Rare Pediatric Priority Review Voucher Read Post »
New Drug ApprovalBayer’s Nubeqa Approved for mHSPC in China Bayer’s Nubeqa Approved for mHSPC in China Read Post »
Clinical TrailsPfizer Bets Big on Monthly GLP-1 After Metsera Deal, VESPER-3 Hits Key Endp... Pfizer Bets Big on Monthly GLP-1 After Metsera Deal, VESPER-3 Hits Key Endp... Read Post »
Health TidingsAstraZeneca Faces FDA Delay for At-Home Saphnelo SC in SLE AstraZeneca Faces FDA Delay for At-Home Saphnelo SC in SLE Read Post »
Clinical TrailsJohnson & Johnson Unveils Real-World Data: ERLEADA Cuts Death Risk by 5... Johnson & Johnson Unveils Real-World Data: ERLEADA Cuts Death Risk by 5... Read Post »
Health TidingsFDA Issues Complete Response Letter for Anaphylm Sublingual Epinephrine Fil... FDA Issues Complete Response Letter for Anaphylm Sublingual Epinephrine Fil... Read Post »
Clinical TrailsPositive Topline Results: Venglustat Succeeds in Sanofi’s LEAP2MONO GD3 S... Positive Topline Results: Venglustat Succeeds in Sanofi’s LEAP2MONO GD3 S... Read Post »
Policy & AcquisitionsIllumina Completes Acquisition of SomaLogic Illumina Completes Acquisition of SomaLogic Read Post »
New Drug ApprovalImfinzi Boosts Survival in Gastric Cancer, Gains CHMP Endorsement Imfinzi Boosts Survival in Gastric Cancer, Gains CHMP Endorsement Read Post »
Clinical TrailsLundbeck INFUSE Study: Vyepti Shines for Hard-to-Treat Migraine Lundbeck INFUSE Study: Vyepti Shines for Hard-to-Treat Migraine Read Post »
Health TidingsFDA Issues CRL for Pharming’s Joenja in Pediatric APDS Patients FDA Issues CRL for Pharming’s Joenja in Pediatric APDS Patients Read Post »
New Drug ApprovalCHMP Backs Rezurock for Chronic GVHD After Re-Examination CHMP Backs Rezurock for Chronic GVHD After Re-Examination Read Post »
New Drug ApprovalIncyte’s Zynyz Wins Positive CHMP Opinion in Advanced Anal Cancer Incyte’s Zynyz Wins Positive CHMP Opinion in Advanced Anal Cancer Read Post »
ResearchMigraine Attacks Disrupt Relationships, AbbVie Report Migraine Attacks Disrupt Relationships, AbbVie Report Read Post »
New Drug ApprovalEMA CHMP Recommends Bayer’s Finerenone for Heart Failure with LVEF â‰... EMA CHMP Recommends Bayer’s Finerenone for Heart Failure with LVEF â‰... Read Post »
New Drug ApprovalJ&J Scores CHMP Nod for AKEEGA in High-Risk Prostate Cancer J&J Scores CHMP Nod for AKEEGA in High-Risk Prostate Cancer Read Post »
New Drug ApprovalFDA Approves Tenpoint’s YUVEZZI Eye Drop for Presbyopia Treatment FDA Approves Tenpoint’s YUVEZZI Eye Drop for Presbyopia Treatment Read Post »
Clinical TrailsUltragenyx Resubmits BLA for UX111 Gene Therapy in Sanfilippo Syndrome Type... Ultragenyx Resubmits BLA for UX111 Gene Therapy in Sanfilippo Syndrome Type... Read Post »
Clinical TrailsTanabe Pharma’s ZYNLONTA® Hits Key Endpoint in Japanese r/r DLBCL Tr... Tanabe Pharma’s ZYNLONTA® Hits Key Endpoint in Japanese r/r DLBCL Tr... Read Post »
Policy & AcquisitionsAstraZeneca Bets Big on Next-Gen Obesity Drugs With CSPC AstraZeneca Bets Big on Next-Gen Obesity Drugs With CSPC Read Post »
Policy & AcquisitionsModerna Partners with Recordati to Advance mRNA-3927 for Propionic Acidemia Moderna Partners with Recordati to Advance mRNA-3927 for Propionic Acidemia Read Post »
Clinical TrailsFDA Grants Class II Review for Unicycive’s Resubmission of OLC in Hyperph... FDA Grants Class II Review for Unicycive’s Resubmission of OLC in Hyperph... Read Post »
Drugs Safety AlertFDA Halts REGENXBIO’s RGX-111 and RGX-121 After CNS Tumor Case FDA Halts REGENXBIO’s RGX-111 and RGX-121 After CNS Tumor Case Read Post »
Policy & AcquisitionsUS Officially Exits WHO in January 2026: Funding Cuts, COVID Fallout, and G... US Officially Exits WHO in January 2026: Funding Cuts, COVID Fallout, and G... Read Post »
Policy & AcquisitionsAstraZeneca Commits $15 Billion to China Expansion by 2030, Boosting Cell T... AstraZeneca Commits $15 Billion to China Expansion by 2030, Boosting Cell T... Read Post »
Clinical TrailsChugai Files Tecentriq for MRD-Positive Bladder Cancer in Japan Chugai Files Tecentriq for MRD-Positive Bladder Cancer in Japan Read Post »
Clinical TrailsBiogen’s Litifilimab Wins FDA Breakthrough Therapy Designation for Cutane... Biogen’s Litifilimab Wins FDA Breakthrough Therapy Designation for Cutane... Read Post »
Policy & AcquisitionsSeamless Therapeutics and Eli Lilly Partner to Advance Programmable Gene Ed... Seamless Therapeutics and Eli Lilly Partner to Advance Programmable Gene Ed... Read Post »
Clinical TrailsFDA Grants Priority Review to Otsuka’s Centanafadine NDA for ADHD Across ... FDA Grants Priority Review to Otsuka’s Centanafadine NDA for ADHD Across ... Read Post »
Policy & AcquisitionsSimcere Signs EUR 1.058B IBD Deal with Boehringer Ingelheim for SIM0709 Simcere Signs EUR 1.058B IBD Deal with Boehringer Ingelheim for SIM0709 Read Post »
New Drug ApprovalFDA Approves JnJ’s DARZALEX FASPRO Quadruplet for NDMM FDA Approves JnJ’s DARZALEX FASPRO Quadruplet for NDMM Read Post »
Clinical TrailsELEVIDYS Delivers 3-Year Sustained Motor Benefits in Ambulatory Duchenne Pa... ELEVIDYS Delivers 3-Year Sustained Motor Benefits in Ambulatory Duchenne Pa... Read Post »
Drugs Safety AlertFDA Lifts Clinical Hold on Intellia’s MAGNITUDE-2 Phase 3 Trial of Nex-z ... FDA Lifts Clinical Hold on Intellia’s MAGNITUDE-2 Phase 3 Trial of Nex-z ... Read Post »
Clinical TrailsNeurocrine Biosciences Launches Phase 2 Trial of NBI-1065890 for Tardive Dy... Neurocrine Biosciences Launches Phase 2 Trial of NBI-1065890 for Tardive Dy... Read Post »
Clinical TrailsRoche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase II... Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase II... Read Post »
Health TidingsCARDAMYST™ Now Available in U.S. Pharmacies: A New Self-Administered Opti... CARDAMYST™ Now Available in U.S. Pharmacies: A New Self-Administered Opti... Read Post »
New Drug ApprovalEU Expands GSK’s Arexvy Approval to All Adults Aged 18 and Older EU Expands GSK’s Arexvy Approval to All Adults Aged 18 and Older Read Post »
Clinical TrailsFDA Accepts Eisai-Biogen’s LEQEMBI IQLIK sBLA Under Priority Review FDA Accepts Eisai-Biogen’s LEQEMBI IQLIK sBLA Under Priority Review Read Post »
Food ResearchBest Diet While on GLP-1 Weight Loss Drugs (Ozempic, Wegovy, Zepbound): Evi... Best Diet While on GLP-1 Weight Loss Drugs (Ozempic, Wegovy, Zepbound): Evi... Read Post »
ResearchClosed-Loop Insulin Delivery Systems: The New Standard Closed-Loop Insulin Delivery Systems: The New Standard Read Post »
Clinical TrailsBausch Health’s RED-C Program Comes Up Short in Phase 3 Bausch Health’s RED-C Program Comes Up Short in Phase 3 Read Post »
Policy & AcquisitionsPfizer Taps Novavax Matrix-M in New Licensing Deal Pfizer Taps Novavax Matrix-M in New Licensing Deal Read Post »
Clinical TrailsAbbott Shares Five-Year Data Showing Neuromodulation Therapy Cuts Pain-Rela... Abbott Shares Five-Year Data Showing Neuromodulation Therapy Cuts Pain-Rela... Read Post »
Clinical TrailsSanofi’s Amlitelimab Strengthens Phase 3 Evidence in Atopic Dermatitis wi... Sanofi’s Amlitelimab Strengthens Phase 3 Evidence in Atopic Dermatitis wi... Read Post »
New Drug ApprovalSun Pharma Wins DCGI Approval for Noveltreat, Generic Semaglutide Injection... Sun Pharma Wins DCGI Approval for Noveltreat, Generic Semaglutide Injection... Read Post »
